←Back to Expert Scholars
Translational Medicine / 转化医学Ovarian Cancer, Rare Gynecologic
Ursula Matulonis
MD
🏢Dana-Farber Cancer Institute🌐USA
Chief, Division of Gynecologic Oncology
85
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Ursula Matulonis is an internationally recognized leader in ovarian cancer who has contributed to registration trials of PARP inhibitors and rare histology studies. She leads Dana-Farber gynecologic oncology and many cooperative group trials. Her work extends to low grade serous and other rare ovarian tumors.
Share:
🧪Research Fields 研究领域
ovarian cancer
rare gynecologic tumors
PARP inhibitors
clinical trials
targeted therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Ursula Matulonis 的研究动态
Follow Ursula Matulonis's research updates
留下邮箱，当我们发布与 Ursula Matulonis（Dana-Farber Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment